MS-282a and MS-282b, new inhibitors of calmodulin-activated myosin light chain kinase from Streptomyces tauricus ATCC 27470.

Authors:
  • KKKatsunori Kita
    Katsunori Kita
  • YUYouichi Uosaki
    Youichi Uosaki
  • MYMayumi Yoshida
    Mayumi Yoshida
  • YSYutaka Saitoh
    Yutaka Saitoh
  • AMAkira Mihara
    Akira Mihara
  • IKIsao Kawamoto
    Isao Kawamoto
  • YMYuzuru Matsuda
    Yuzuru Matsuda

Abstract
MS-282a and MS-282b were isolated from the culture broth of Streptomyces tauricus ATCC 27470 as inhibitors of smooth muscle myosin light chain kinase (MLCK). MS-282a and MS-282b inhibited the activity of chicken gizzard MLCK with IC50 values of 3.8 microM and 5.2 microM, respectively. Cyclic AMP-dependent protein kinase, cyclic GMP-dependent protein kinase and protein kinase C were not inhibited by 150 microM MS-282a at all. It is likely that MS-282a blocks MLCK activity by antagonizing calmodulin since 1) the compound inhibited calmodulin-dependent but not calmodulin-independent activity of MLCK; 2) the inhibition of MLCK was antagonized by increasing concentrations of calmodulin, and 3) the compound inhibited calmodulin-dependent cyclic nucleotide phosphodiesterase.